NCT07529873 2026-04-14N'FORCEGroupe Oncologie Radiotherapie Tete et CouPhase 2 Not yet recruiting131 enrolled
NCT07460765 2026-03-10Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)Vanderbilt-Ingram Cancer CenterPhase 1 Not yet recruiting40 enrolled
NCT07216833 2025-10-15Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckCase Comprehensive Cancer CenterPhase 1 Not yet recruiting15 enrolled